Analysis of lymph mode recurrence in patients with melanoma and sentinel lymph mode negative. Retrospective study at the Hospital Saint-Louis, Paris;Évaluation du taux de récidive ganglionnaire après ganglion sentinelle négatif chez les patients porteurs de mélanome, et analyse des résultats. L'expérience de l'hôpital Saint-Louis, Paris

Annales de Chirurgie Plastique Esthetique

Volumn 50, Issue 2, 2005, Pages 104-112

  Derhy, Y ^a,b   Kerob, D ^a   Verola, O ^a   Binder, J P ^a   Lebbe, C ^a   Revol, M ^a   Servant, J M ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE   (France)

Author keywords

Melanoma; Occult metastasis; Regional recurrence; Sentinel lymph node

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; FEMALE; FRANCE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TIME SERIES ANALYSIS; ULCER; ADOLESCENT; HOSPITAL; METASTASIS; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PARIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 17144397497     PISSN: 02941260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anplas.2004.11.004     Document Type: Article

References (37)

1. D.L. Morton, D.R. Wen, J.H. Wong, J.S. Economou, L.A. Cagle, and F.K. Storm Technical details of intraoperative lymphatic mapping for early stage melanoma Arch. Surg. 27 1992 392
2. C.M. Balch, A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, and D.G. Coit Final version of the American Joint Comittee on Cancer Staging system for cutaneous melanoma J. Clin. Oncol. 19 2001 3635
3. J. Shen, A.M. Wallace, and M. Bouvet The role of sentinel lymph node biopsy for melanoma Semin. Oncol. 29 2002 341 352
4. R. Russel-Jones, and K. Acland Sentinel lymph node biopsy in the management of malignant melanoma Clinical Experimental Dermatology 26 2001 463 468
5. C.M. Balch, S.J. Soong, and A.A. Bartolucci Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger Ann. Surg. 224 1996 255 263
6. J.J. Grobb, B. Dreno, P. De La Salmoniere, M. Delaunay, D. Cupissol, and B. Guillot Randomised trial of interferon alpha 2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastasis. French Cooperative Group on Melanoma Lancet 351 1998 1905 1910
7. J.E. Gershenwald, W. Thompson, and P.F. Mansfield Multi institutional melanoma lymphatic mapping experience: prognosis value of sentinel lymph node status in 612 stage I or II melanoma patients J. Clin. Oncol. 17 1999 973 983
8. N. Cascinelli, A. Morabito, and M. Santinami Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. WHO Melanoma Program Lancet. 351 1998 793 796
9. F.J. Sims, T.I. Nelson, and D.J. Pritchard Malignant melanoma: MayoClinic experience Mayo Clin. Proc. 72 1997 5655 5659
10. S.P. Leong, E. Donegan, and W. Heffernon Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma Ann. Surg. Oncol. 7 2000 361 366
11. J.J. Albertini, C.W. Cruse, D. Rapaport, K. Wells, M. Ross, and R. De Conti Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma Ann. Surg. 223 1996 217 224
12. S.P. Leong The role of sentinel lymph nodes in malignant melanoma Surg. Clin. North Am. 80 2000 1741 1757
13. D.N. Krag, and D.L. Weaver Pathological and molecular assessment of sentinel lymph nodes in solid tumors Semin. Oncol. 29 2002 274 279
14. X. Wang, R. Heller, N. Van Voorhis, C.W. Cruse, F. Glass, and N. Fenske Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients xith malignant melanoma Ann. Surg. 220 1994 768 774
15. N. Cascinelli, F. Belli, and M. Santinami Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience Ann. Surg. Oncol. 7 2000 469 474
16. J.F. Thompson, W.H. Mc Carthy, and C.M. Bosch Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes Melanoma Res. 5 1995 255 260
17. L.L. Ling-Xi, R.A. Scolyer, S.K. Vivian, J. Gregory Mckinnon, H.M. Shaw, and S.W. Mccarthy Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy Am. J. Surg. Pathol. 27 9 2003 1197 1202
18. J.E. Gershenwald, M.J. Colome, and J.E. Lee Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J. Clin. Oncol. 16 1998 2253 2260
19. E. Joseph, A. Borbeil, F. Glass, and J. Glass Results of complete lymph node dissection in 83 melanoma patients with positivity of sentinel nodes Ann. Surg. Oncol. 5 1998 119 125
20. T.M. Johnson, A.M. Yahanda, A.E. Chang, D.J. Fader, and V.K. Sondak Advances in melanoma therapy J. Am. Acad. Dermatol. 38 1998 731 741
21. M.A. Gad, A.B. Cosimi, and J. Yu Outcome of patients with melanoma and histologically negative sentinel lymph nodes Arch. Surg. 134 1999 381 387
22. T.J. Yu Ll Flotte, and K.K. Tanabe Detection of microscopic melanoma metastases in sentinel lymph nodes Cancer 86 1999 617 627
23. A.J. Cochran Surgical pathology remains pivotal in the evaluation of sentinel lymph nodes Am. J. Surg. Pathol. 23 10 1999 1169 1172
24. A.J. Cochran The pathologist's role in sentinel lymph node evaluation Semin. Nucl. Med. 30 2000 11 17
25. M.G. Cook, M.A. Green, B. Anderson, A.M.M. Eggermont, D.J. Ruiter, A. Spatz on behalf of the EORTC Melanoma Group The development of optimal pathological assessment of sentinel lymph nodes for melanoma J. Pathol. 200 2003 314 319
26. D.N. Krag, S.J. Mejer, and D.L. Weaver Minimal-access surgery for staging of melanoma Arch. Surg. 130 1995 654 658
27. S.C. Shivers, X. Wang, and W. Li Molecular stagigng of malignant melanoma JAMA 280 1998 1410 1415
28. H.J. Blaheta, U. Ellwanger, and B. Schittek Examination of regional lymph nodes by sentinel nodes biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma J. Invest. Dermatol. 14 2000 637 642
29. B. Taback, D.L. Morton, and S.J. O'day The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma Recent Results Cancer Res. 15 2001 78 92
30. D.S. Reintgen, S. Cruse, and C. Berman An orderly progression of melanoma nodal metastases Ann. Surg. 220 1994 759 767
31. JE Gershenwald. W Thompson, PF Mansfield et al. Patterns of failure in melanoma patients after successful lymphatic mapping and negative sentinel node biopsy. Presented at the Forty-Ninth Annual Meeting of The Society of Surgical Oncology, Atlanta, GA, March 21-24, 1996 (abstr).
32. M.C. Thelmo, Morita, and P.A. Treseler Micrometastasis to In-Transit Lymph nodes from extremity and truncal malignant melanoma Ann. Surg. Oncol. 8 2001 444 448
33. A.D. Chan, and D.L. Morton Sentinel node detection in malignant melanoma Recent Results Cancer Res. 157 2000 161 177
34. D.L. Morton, D.R. Wen, and L.J. Foshag Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early stages melanoma of the head and neck J. Clin. Oncol. 11 1993 1751 1756
35. S.D. Nathanson Will the true sentinel node please stand? Ann. Surg. Oncol. 6 1999 514 516
36. D. Krag, D. Weaver, and T. Ashikaga The sentinel node in breast cancer - a multicenter validation study N. Engl. J. Med. 339 1998 941 946
37. M. Kelly Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann. Surg. Oncol. 8 2001 192 197